Monte Rosa Therapeutics
GLUE
GLUE
71 hedge funds and large institutions have $227M invested in Monte Rosa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.
Holders
71
Holders Change
–
Holders Change %
0%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
15
Reduced
25
Closed
13
Calls
$2.9M
Puts
$1.24M
Net Calls
+$1.66M
Net Calls Change
+$888K
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$27.9M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$5.56M |
3 |
3
Morgan Stanley
New York
|
$921K |
4 |
CM
4
Caption Management
Oklahoma City,
Oklahoma
|
$512K |
5 |
5
Jane Street
New York
|
$400K |